KCNN4 and cardiovascular disorder: Functional evidence for targeting pathway of impaired KCa3.1/KCa2.3-EDH–dilator system would raise the possibility to improve vascular function [3] and could serve the way for new treatment for hypertension and related cardiovascular diseases [9].